Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 30.38
-3.02 (-9.04%)
At close: May 30, 2025, 2:57 PM CST
SHE:301258 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 442.8 | 426.01 | 483.1 | 548.95 | 511.66 | 466.86 | Upgrade
|
| Other Revenue | 3.46 | 3.46 | 6.19 | 19.26 | 10.03 | 9.98 | Upgrade
|
| Revenue | 446.26 | 429.47 | 489.29 | 568.21 | 521.7 | 476.85 | Upgrade
|
| Revenue Growth (YoY) | 4.00% | -12.23% | -13.89% | 8.92% | 9.40% | 5.38% | Upgrade
|
| Cost of Revenue | 366.91 | 348.04 | 301.22 | 314.9 | 314.25 | 252.16 | Upgrade
|
| Gross Profit | 79.36 | 81.43 | 188.07 | 253.31 | 207.45 | 224.69 | Upgrade
|
| Selling, General & Admin | 45.82 | 46.58 | 50.89 | 47.65 | 37.44 | 35.32 | Upgrade
|
| Research & Development | 38.23 | 40.62 | 40.7 | 41.37 | 28.51 | 22.88 | Upgrade
|
| Other Operating Expenses | 2.48 | 1.89 | 4.78 | 5.1 | 4.11 | 4.28 | Upgrade
|
| Operating Expenses | 88.94 | 90.59 | 95.18 | 94.54 | 70.41 | 61.98 | Upgrade
|
| Operating Income | -9.58 | -9.16 | 92.89 | 158.77 | 137.04 | 162.71 | Upgrade
|
| Interest Expense | -0.08 | -0.09 | -0.12 | -0.31 | -0.45 | - | Upgrade
|
| Interest & Investment Income | 47.65 | 46.94 | 28.96 | 8.2 | 4.62 | 9.32 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.36 | 3.36 | 1.48 | 31.6 | -5.5 | -6.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.55 | -0.2 | -0.19 | -0.09 | -0.27 | -0.28 | Upgrade
|
| EBT Excluding Unusual Items | 40.8 | 40.85 | 123.02 | 198.17 | 135.44 | 165.59 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11.07 | -10.3 | 6.31 | -0.86 | 1.61 | -1.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.95 | -0.93 | -0.39 | - | - | - | Upgrade
|
| Asset Writedown | -13.76 | -14.36 | -3.97 | -1.85 | -1.11 | -2.06 | Upgrade
|
| Other Unusual Items | 2.95 | 2.95 | 3.58 | 7.01 | 2.49 | 2.41 | Upgrade
|
| Pretax Income | 40.11 | 18.21 | 128.54 | 202.46 | 138.44 | 164.83 | Upgrade
|
| Income Tax Expense | 5.55 | 1.81 | 16.36 | 25.15 | 18.24 | 23.78 | Upgrade
|
| Net Income | 34.56 | 16.41 | 112.18 | 177.31 | 120.2 | 141.05 | Upgrade
|
| Net Income to Common | 34.56 | 16.41 | 112.18 | 177.31 | 120.2 | 141.05 | Upgrade
|
| Net Income Growth | -47.93% | -85.38% | -36.73% | 47.51% | -14.78% | -3.20% | Upgrade
|
| Shares Outstanding (Basic) | 91 | 91 | 92 | 86 | 69 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 91 | 91 | 92 | 86 | 69 | 69 | Upgrade
|
| Shares Change (YoY) | -1.14% | -0.88% | 6.83% | 25.31% | -0.17% | 2.00% | Upgrade
|
| EPS (Basic) | 0.38 | 0.18 | 1.22 | 2.06 | 1.75 | 2.05 | Upgrade
|
| EPS (Diluted) | 0.38 | 0.18 | 1.22 | 2.06 | 1.75 | 2.05 | Upgrade
|
| EPS Growth | -47.33% | -85.25% | -40.78% | 17.71% | -14.63% | -5.09% | Upgrade
|
| Free Cash Flow | -80.96 | -58.25 | 53.15 | 101.08 | 118.98 | 101.16 | Upgrade
|
| Free Cash Flow Per Share | -0.89 | -0.64 | 0.58 | 1.17 | 1.73 | 1.47 | Upgrade
|
| Dividend Per Share | 0.091 | 0.091 | 0.600 | 0.580 | 0.400 | 0.700 | Upgrade
|
| Dividend Growth | -84.83% | -84.83% | 3.45% | 45.00% | -42.86% | -7.90% | Upgrade
|
| Gross Margin | 17.78% | 18.96% | 38.44% | 44.58% | 39.77% | 47.12% | Upgrade
|
| Operating Margin | -2.15% | -2.13% | 18.98% | 27.94% | 26.27% | 34.12% | Upgrade
|
| Profit Margin | 7.74% | 3.82% | 22.93% | 31.20% | 23.04% | 29.58% | Upgrade
|
| Free Cash Flow Margin | -18.14% | -13.56% | 10.86% | 17.79% | 22.81% | 21.21% | Upgrade
|
| EBITDA | 36.23 | 38.69 | 148.89 | 210.37 | 183.15 | 196.29 | Upgrade
|
| EBITDA Margin | 8.12% | 9.01% | 30.43% | 37.02% | 35.11% | 41.16% | Upgrade
|
| D&A For EBITDA | 45.82 | 47.85 | 56 | 51.61 | 46.11 | 33.58 | Upgrade
|
| EBIT | -9.58 | -9.16 | 92.89 | 158.77 | 137.04 | 162.71 | Upgrade
|
| EBIT Margin | -2.15% | -2.13% | 18.98% | 27.94% | 26.27% | 34.12% | Upgrade
|
| Effective Tax Rate | 13.84% | 9.92% | 12.73% | 12.43% | 13.18% | 14.43% | Upgrade
|
| Revenue as Reported | 446.26 | 429.47 | 489.29 | 568.21 | 521.7 | 476.85 | Upgrade
|
| Advertising Expenses | - | - | - | 1.19 | - | - | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.